Company Overview
Snapshot
Founded in January 2025 by Limor Prigan (Ben-Asher) and Eran Yarkoni, LumenGuides operates with 1–10 employees. The company has raised $3.85M across two funding rounds. In March 2026, LumenGuides secured a grant from the Israel Innovation Authority, highlighting its innovative approach to pulmonary care.
Business overview
LumenGuides develops Naviscope, an AI-powered navigation system designed to access previously unreachable tumors within the lungs. This technology enhances bronchoscopy by enabling early-stage biopsies and precise, minimally invasive interventions. The system utilizes a single-use, autonomous endoluminal device to improve the safety, speed, and accuracy of pulmonary diagnostics and treatments. By expanding access to hard-to-reach areas and supporting earlier detection, LumenGuides aims to significantly improve outcomes in the Digital Medical Diagnostics sector, serving the broader Healthcare & Life Sciences market.
Strategic signal
In March 2026, LumenGuides received a grant from the Israel Innovation Authority. This non-equity funding validates the company's innovative AI-powered navigation system for pulmonary interventions, signaling strong governmental support and recognition of its potential to advance medical diagnostics and treatment in the health tech sector.
Company Intelligence Q&A
- When was LumenGuides founded and by whom?
- LumenGuides was founded in January 2025 by co-founders Limor Prigan (Ben-Asher) and Eran Yarkoni.
- What is the primary product developed by LumenGuides?
- LumenGuides has developed Naviscope, an AI-powered navigation system designed to access previously unreachable tumors within the lungs, enhancing bronchoscopy for early-stage biopsies and precise interventions.
- What significant funding did LumenGuides receive in March 2026?
- In March 2026, LumenGuides secured a grant from the Israel Innovation Authority for its innovative work in pulmonary care.
- What is the total capital raised by LumenGuides?
- LumenGuides has raised a total of $3.85M across two funding rounds.
- What problem does LumenGuides aim to solve in pulmonary care?
- LumenGuides aims to improve outcomes in pulmonary care by enabling access to hard-to-reach areas of the lungs and supporting earlier detection of tumors through its AI-powered navigation system.